UNIGE document Scientific Article
previous document  unige:106613  next document
add to browser collection
Title

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030

Authors
Bruggmann, Philip
Blach, Sarah
Deltenre, Pierre
Fehr, Jan
Kouyos, Roger
Lavanchy, Daniel
Müllhaupt, Beat
Rauch, Andri
show hidden authors show all authors [1 - 13]
Published in Swiss Medical Weekly. 2017, vol. 147, p. w14543
Abstract In Switzerland, the prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) has been decreasing owing to active harm reduction efforts and an aging population. Recent advances in HCV therapeutics may provide an opportunity to direct treatment to high-risk populations, with a goal of reducing HCV prevalence and preventing new infections. In order to guide these efforts, the current project was undertaken with the following aims: (1) to develop a simple model to estimate the number of new HCV infections using available data on PWID; (2) to examine the impact of intervention strategies (prevention and treatment) on new and total HCV infections among PWID.
Identifiers
PMID: 29120012
Full text
Article (Published version) (1.4 MB) - public document Free access
Structures
Research group Etudes et traitement de l'hépatite C et B (554)
Citation
(ISO format)
BRUGGMANN, Philip et al. Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030. In: Swiss Medical Weekly, 2017, vol. 147, p. w14543. https://archive-ouverte.unige.ch/unige:106613

11 hits

3 downloads

Update

Deposited on : 2018-07-24

Export document
Format :
Citation style :